Skip to main content
Tech.euFundingExplorerBeta

Pfizer Ventures

Investor profile

Venture capital

Pfizer Ventures has backed 17 European tech companies across 23 funding rounds between 2016 and 2026, joining rounds totalling €890M. Most active in Healthtech and Fintech. Data as of Nov 2026.

Also recorded as: Pfizer · Pfizer Venture Investments

Deals
23
distinct rounds
Companies
17
backed
Active span
2016–2026
11 yrs
Total round €
€890M
sum of rounds joined

Deals by year

distinct rounds / year
Pfizer Ventures — deals by year — interactive chart.
Data table
Pfizer Ventures — deals by year
20162
20181
20192
20202
20212
20224
20232
20243
20254
20261

Top sectors

by deals
Pfizer Ventures — top sectors — interactive chart.
Data table
Pfizer Ventures — top sectors
Healthtech22
Fintech1

Stages

by deals
Pfizer Ventures — stages — interactive chart.
Data table
Pfizer Ventures — stages
Series B8
Other5
Series A5
Series C2
Early VC1
Seed1
Series D+1

Countries

by deals
Pfizer Ventures — countries — interactive chart.
Data table
Pfizer Ventures — countries
UK10
Switzerland6
France3
Belgium1
Germany1
Israel1
Sweden1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Pfizer Ventures — 23 dealsPfizer VenturesM Ventures — 7 shared deals · click to openM VenturesAndera Partners — 3 shared deals · click to openAndera PartnersBioMedPartners — 3 shared deals · click to openBioMedPartnersBritish Patient Capital — 3 shared deals · click to openBritish Patient CapitalGIMV — 3 shared deals · click to openGIMVIP Group PLC — 3 shared deals · click to openIP Group PLCNovartis Venture Fund — 3 shared deals · click to openNovartis Venture FundOxford Science Enterprises — 3 shared deals · click to openOxford Science EnterprisesBpifrance — 2 shared deals · click to openBpifranceCambridge Innovation Capital — 2 shared deals · click to openCambridge Innovation CapitalCanaan Partners — 2 shared deals · click to openCanaan PartnersEarlybird Venture Capital — 2 shared deals · click to openEarlybird Venture CapitalEQT Life Sciences — 2 shared deals · click to openEQT Life SciencesMission BioCapital — 2 shared deals · click to openMission BioCapitalOmega Funds — 2 shared deals · click to openOmega FundsPontifax Funds — 2 shared deals · click to openPontifax FundsSofinnova Partners — 2 shared deals · click to openSofinnova PartnersTaiho Ventures — 2 shared deals · click to openTaiho Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
AnaveonSwitzerland1€105M
Imcheck TherapeuticsFrance2€103M
ArtiosUK1€99M
Immunos TherapeuticsSwitzerland3€92M
Grey Wolf TherapeuticsUK2€87M
Storm TherapeuticsUK2€76M
Anjarium BiosciencesSwitzerland1€51M
Vivet TherapeuticsFrance1€45M
FoRx TherapeuticsSwitzerland1€43M
Agomab TherapeuticsBelgium1€41M
Nucleome TherapeuticsUK1€38M
Enara BioUK1€29M
Trimtech TherapeuticsUK1€29M
MISSION TherapeuticsUK2€25M
MetabomedIsrael1€16M
AmraSweden1€8.2M
VitaDAOGermany1€3.8M

Biggest deals

top 10 by amount
CompanyStageAmountDate
AnaveonSeries B€105M2021-12
ArtiosSeries D+€99M2025-11
Immunos TherapeuticsSeries B€68M2022-06
Imcheck TherapeuticsOther€54M2020-09
Anjarium BiosciencesSeries A€51M2021-09
Imcheck TherapeuticsSeries B€49M2019-10
Storm TherapeuticsSeries C€48M2026-04
Vivet TherapeuticsOther€45M2019-01
Grey Wolf TherapeuticsSeries B€45M2023-01
FoRx TherapeuticsSeries A€43M2025-12
← Back to investors